Developer docs
API playgroundTry for free, no card

Search company profiles

Syncell

Full company profile

uuid0000dgg

Namestring
Syncell
Legal namestring
SYNCELL, Inc.
Websiteurl
syncell.com
Company typeenum
Private
Founded yearint
2020
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersTaipei, Taiwan
HQ citystring
Taipei
HQ countrystring
Taiwan
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spatial proteomics, subcellular proteomics, photobiotinylation reagents, biomarker discovery, mass spectrometry workflows
Industry2 codes
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Spatial Proteomics Instruments
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Microscoop Mint Instruments
TypeHardware Sales
Description

Sale of the Microscoop Mint platform - an integrated hardware/software system for spatial proteomics. System includes optical engine, electrical controller, microscope, camera, software package, and two-photon laser.

syncell.com
2Reagent Kits (Synlight and Synpull)
TypeHardware Sales
Description

Proprietary reagent kits including Synlight-Rich, Synlight-Pure, and Synpull reagents. Consumable products designed for single-use with the Microscoop platform. Synlight reagents are specifically designed to integrate with the Microscoop system for spatial protein purification.

syncell.com
3Discovery Services
TypeProfessional Services
Description

End-to-end proteomics discovery services using the Microscoop platform. Minimum project budget of $50,000 with at least 3 biological replicates. Includes microscopy-targeted ROI selection, automated photolabeling, mass spectrometry analysis, and scientific reporting with prioritized hypotheses.

syncell.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels12 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details5 tiers
1Discovery Services - Signature Discovery Project
ModelOtherBilling cadenceMulti-year contract
Notes

Baseline proteomic signature for one region/condition. Ideal for early target or pathway exploration. Minimum engagement $50,000 for at least 3 biological replicates.

syncell.com
2Discovery Services - Comparative Profiling Project
ModelOtherBilling cadenceMulti-year contract
Notes

Contrast proteomes across conditions (e.g., treated vs control). Ideal for hypothesis testing and mechanistic understanding. Minimum engagement $50,000.

syncell.com
3Discovery Services - Program Partnership
ModelOtherBilling cadenceMulti-year contract
Notes

Multi-study engagements with strategic design and ongoing scientific collaboration. Custom pricing based on scope.

syncell.com
4Microscoop Mint Platform
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Instrument system sale including optical engine, controller, microscope, camera, software. One-year warranty included with optional extended warranty.

syncell.com
5Reagent Kits (Synlight/Synpull)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Consumable reagent kits for single-use applications. Quote-based pricing.

syncell.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Microscoop Mint
Description

The flagship spatial proteomics platform enabling high-precision, unbiased discovery of the entire proteome at cellular and subcellular levels using microscopy-guided photo-biotinylation.

syncell.com
+4 more records
Core offering1 text field

Syncell provides a spatial proteomics platform centered on the Microscoop Mint instrument, an integrated hardware-software-mechatronic system that uses microscopy-guided two-photon photo-biotinylation to enable unbiased, high-precision protein discovery at cellular and subcellular levels. The platform is complemented by proprietary consumable reagent kits (Synlight-Rich, Synlight-Pure, and Synpull) for photolabeling and biotinylated protein enrichment, as well as end-to-end discovery services for target and biomarker identification in pharma, biotech, and academic research settings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1,754 consistently enriched stress granule proteins identified with 96% specificity among top 50 ranked proteins
+3 more records
Product overview1 text field

Syncell offers a unified spatial proteomics platform centered on the Microscoop Mint instrument, combined with proprietary reagent kits (Synlight-Rich, Synlight-Pure, and Synpull) that work together to enable microscopy-guided photobiotinylation and proteomic discovery at subcellular and nanoscopic precision. The platform is complemented by Discovery Services that provide outsourced project support from sample preparation through data analysis.

Product and service5 records
1Microscoop Mint
CategorySpatial Proteomics Instrument
Description

An integrated mechatronic spatial proteomics platform combining an inverted epifluorescence microscope, a two-photon laser for photobiotinylation, and Autoscoop software for automated region-of-interest selection. Designed for pharmaceutical, biotech, and academic researchers who require unbiased protein discovery at cellular and subcellular resolution on FFPE, fresh frozen tissue, and fixed cell samples.

2Synlight-Rich Kit
CategoryReagent Kit
Description

A photobiotinylation reagent kit delivering approximately 350 nm xy and 1.5 μm z effective resolution for broad, site-directed photolabeling of unbiased proteomes in cells or subcellular compartments. Intended for life science researchers using the Microscoop system for high-sensitivity proteomic discovery in regions without known markers.

3Synlight-Pure Kit
CategoryReagent Kit
Description

Ultra-high-precision photolabeling reagent kit offering 25 nm labeling precision with antibody-mediated chemistry coupled with laser-activated precision. Targets researchers probing neighborhood proteomes, cell membranes, small organelles, organelle contact sites, and small pathological aggregates at nanoscopic resolution.

4Synpull Kit
CategoryReagent Kit
Description

Purpose-built enrichment kit for high-efficiency recovery of biotinylated proteins following photolabeling on the Microscoop Mint platform. Uses optimized chemistry for clean enrichment and compatibility with bottom-up proteomic analysis using LC-MS/MS.

5Syncell Discovery Services
CategoryDiscovery Services
Description

End-to-end proteomics discovery services providing microscopy-targeted ROI selection, automated nanoscopic photolabeling, mass spectrometry analysis, statistical interpretation, and scientific reporting. Includes Signature Discovery, Comparative Profiling, and Program Partnership tiers. Minimum project budget of $50,000 with at least three biological replicates.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2025-08-14
Description

Strategic co-marketing agreement to advance high-resolution spatial proteomics. Combines Syncell's Microscoop platform with Thermo Fisher's Orbitrap Astral mass spectrometer series. Leverages Thermo Fisher's global commercial footprint and installed proteomics base to accelerate adoption of unbiased proteome-scale spatial proteomics.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-04-24
Description

Service partner in Preferred Partner Network. CRO specializing in mass spectrometry-based proteomics with over 70,000 samples processed and 12,000+ projects completed. Supports drug discovery, biomarker development, and basic research through comprehensive proteomics services.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-04-24
Description

Service partner in Preferred Partner Network announced in April 2025 as part of expanded commercial capabilities.

4Academia Sinica
Strategic tierFoundationalTypeTechnology or IntegrationAnnounced on2017-01-01
Description

Source of foundational optoproteomics technology IP. Syncell exclusively licenses patents (US Pat. No. 11,265,449 and US Pat. No. 11,789,251) developed at Academia Sinica. Technology prototyping began at Academia Sinica in 2015.

syncell.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Developer of MIBI (Multiplexed Ion Beam Imaging) spatial proteomics technology. Niche competitor in high-multiplex spatial tissue proteomics with comparable subcellular resolution capabilities.

TypeDirect peer
Description

Dominant spatial biology platform company offering Visium (spatial transcriptomics) and Xenium (in situ imaging) platforms. Direct competitor to Syncell in spatial omics, serving the same pharma and academic customers with adjacent technology approaches.

TypeDirect peer
Description

Spatial proteomics company offering the PhenoCycler (CODEX) and PhenoImager platforms for multiplexed tissue imaging. Competes with Syncell for translational and immuno-oncology spatial proteomics budgets in pharma and academic core facilities.

TypeDirect peer
Description

Spatial transcriptomics company using MERFISH technology for single-cell gene expression imaging. Competes with Syncell in the broader spatial omics market, particularly for neuroscience and oncology research applications.

TypeBroad incumbent
Description

Acquired NanoString in 2024 and continues to offer CosMx SMI and GeoMx spatial biology platforms. Also a key mass spec instrumentation partner for Syncell through its timsTOF line, making it both a competitor and a complementary tool provider.

TypeEmerging player
Description

Rebranded from Fluidigm, offering mass cytometry (Hyperion) and spatial proteomics capabilities. Has overlapping academic core facility customers with Syncell but with a different technological approach (metal-tagged antibodies vs. photobiotinylation).

TypeEmerging player
Description

Spatial omics company offering Molecular Cartography for subcellular transcriptomics and proteomics. Competes for spatial biology budget in pharma and translational research with a single-cell resolution imaging approach.

TypeBroad incumbent
Description

Global life sciences instruments leader with Orbitrap mass spectrometer franchise (Orbitrap Astral). Has co-marketing partnership with Syncell but is also a potential competitive threat if it bundles proteomics upstream sample prep with its mass spec business.

TypeBroad incumbent
Description

Major life science tools provider offering MACS proximity labeling (based on technology from the Ting lab) and other spatial biology workflows. Competes indirectly in spatial proteomics with broader cell biology and flow cytometry portfolios.

TypeEmerging player
Description

Spatial biology company offering the COMET platform for multiplex sequential immunofluorescence-based spatial proteomics. Acquired by Bio-Techne, making it a more well-capitalized competitor for tissue-based spatial proteomics applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Syncell

Spatial Proteomics Instrumentssyncell.com

Syncell firmographics

Firmographics
Name
Syncell
Legal name
SYNCELL, Inc.
Website
https://syncell.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Syncell industry classification

Industry
Product category
Spatial Proteomics Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing

Keywords

  • Spatial proteomics
  • Subcellular proteomics
  • Photobiotinylation reagents
  • Biomarker discovery
  • Mass spectrometry workflows

Where Syncell is headquartered

Location

Headquarters

HQ city
Taipei
HQ country
Taiwan
HQ region
Asia

Offices4 records

Markets served

Syncell business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Microscoop Mint Instruments: Sale of the Microscoop Mint platform - an integrated hardware/software system for spatial proteomics. System includes optical engine, electrical controller, microscope, camera, software package, and two-photon laser.
  2. Reagent Kits (Synlight and Synpull): Proprietary reagent kits including Synlight-Rich, Synlight-Pure, and Synpull reagents. Consumable products designed for single-use with the Microscoop platform. Synlight reagents are specifically designed to integrate with the Microscoop system for spatial protein purification.
  3. Discovery Services: End-to-end proteomics discovery services using the Microscoop platform. Minimum project budget of $50,000 with at least 3 biological replicates. Includes microscopy-targeted ROI selection, automated photolabeling, mass spectrometry analysis, and scientific reporting with prioritized hypotheses.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractDiscovery Services - Signature Discovery Project
OtherMulti-year contractDiscovery Services - Comparative Profiling Project
OtherMulti-year contractDiscovery Services - Program Partnership
One time/ perpetual licenseMulti-year contractMicroscoop Mint Platform
Unit PricingPay-as-you-goReagent Kits (Synlight/Synpull)

Go-to-market motion3 records

Distribution channels12 records

Marketing channels8 records

Syncell product offering

Product offering

Core offering

Syncell provides a spatial proteomics platform centered on the Microscoop Mint instrument, an integrated hardware-software-mechatronic system that uses microscopy-guided two-photon photo-biotinylation to enable unbiased, high-precision protein discovery at cellular and subcellular levels. The platform is complemented by proprietary consumable reagent kits (Synlight-Rich, Synlight-Pure, and Synpull) for photolabeling and biotinylated protein enrichment, as well as end-to-end discovery services for target and biomarker identification in pharma, biotech, and academic research settings.

Product overview

Syncell offers a unified spatial proteomics platform centered on the Microscoop Mint instrument, combined with proprietary reagent kits (Synlight-Rich, Synlight-Pure, and Synpull) that work together to enable microscopy-guided photobiotinylation and proteomic discovery at subcellular and nanoscopic precision. The platform is complemented by Discovery Services that provide outsourced project support from sample preparation through data analysis.

Differentiator

Problem solved

Functional benefit

Brands

  • Microscoop Mint: The flagship spatial proteomics platform enabling high-precision, unbiased discovery of the entire proteome at cellular and subcellular levels using microscopy-guided photo-biotinylation.
  • Synlight
  • Synlight-Rich
  • Synlight-Pure
  • Synpull

Products and services

  • Microscoop Mint An integrated mechatronic spatial proteomics platform combining an inverted epifluorescence microscope, a two-photon laser for photobiotinylation, and Autoscoop software for automated region-of-interest selection. Designed for pharmaceutical, biotech, and academic researchers who require unbiased protein discovery at cellular and subcellular resolution on FFPE, fresh frozen tissue, and fixed cell samples.
  • Synlight-Rich Kit A photobiotinylation reagent kit delivering approximately 350 nm xy and 1.5 μm z effective resolution for broad, site-directed photolabeling of unbiased proteomes in cells or subcellular compartments. Intended for life science researchers using the Microscoop system for high-sensitivity proteomic discovery in regions without known markers.
  • Synlight-Pure Kit Ultra-high-precision photolabeling reagent kit offering 25 nm labeling precision with antibody-mediated chemistry coupled with laser-activated precision. Targets researchers probing neighborhood proteomes, cell membranes, small organelles, organelle contact sites, and small pathological aggregates at nanoscopic resolution.
  • Synpull Kit Purpose-built enrichment kit for high-efficiency recovery of biotinylated proteins following photolabeling on the Microscoop Mint platform. Uses optimized chemistry for clean enrichment and compatibility with bottom-up proteomic analysis using LC-MS/MS.
  • Syncell Discovery Services End-to-end proteomics discovery services providing microscopy-targeted ROI selection, automated nanoscopic photolabeling, mass spectrometry analysis, statistical interpretation, and scientific reporting. Includes Signature Discovery, Comparative Profiling, and Program Partnership tiers. Minimum project budget of $50,000 with at least three biological replicates.

Quantifiable outcome

  • 1,754 consistently enriched stress granule proteins identified with 96% specificity among top 50 ranked proteins
  • +3 more outcomes

Companies that use Syncell

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Syncell technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature6 records

Syncell partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered flagship, core and foundational.

  • Thermo Fisher ScientificflagshipGTM or Marketing Partner · 14 August 2025Strategic co-marketing agreement to advance high-resolution spatial proteomics. Combines Syncell's Microscoop platform with Thermo Fisher's Orbitrap Astral mass spectrometer series. Leverages Thermo Fisher's global commercial footprint and installed proteomics base to accelerate adoption of unbiased proteome-scale spatial proteomics.
  • MS BioworkscoreImplementation/ SI/ Consulting Partner · 24 April 2025Service partner in Preferred Partner Network. CRO specializing in mass spectrometry-based proteomics with over 70,000 samples processed and 12,000+ projects completed. Supports drug discovery, biomarker development, and basic research through comprehensive proteomics services.
  • OMAPiXcoreImplementation/ SI/ Consulting Partner · 24 April 2025Service partner in Preferred Partner Network announced in April 2025 as part of expanded commercial capabilities.
  • Academia SinicafoundationalTechnology or Integration · 1 January 2017Source of foundational optoproteomics technology IP. Syncell exclusively licenses patents (US Pat. No. 11,265,449 and US Pat. No. 11,789,251) developed at Academia Sinica. Technology prototyping began at Academia Sinica in 2015.

Scale indicators4 records

Recent moves8 records

Expansion highlights7 records

Syncell competitors and assessment

Company assessment

Emerging players

  • Ionpath: Developer of MIBI (Multiplexed Ion Beam Imaging) spatial proteomics technology. Niche competitor in high-multiplex spatial tissue proteomics with comparable subcellular resolution capabilities.
  • Standard BioTools (Fluidigm): Rebranded from Fluidigm, offering mass cytometry (Hyperion) and spatial proteomics capabilities. Has overlapping academic core facility customers with Syncell but with a different technological approach (metal-tagged antibodies vs. photobiotinylation).
  • Resolve Biosciences: Spatial omics company offering Molecular Cartography for subcellular transcriptomics and proteomics. Competes for spatial biology budget in pharma and translational research with a single-cell resolution imaging approach.
  • Lunaphore: Spatial biology company offering the COMET platform for multiplex sequential immunofluorescence-based spatial proteomics. Acquired by Bio-Techne, making it a more well-capitalized competitor for tissue-based spatial proteomics applications.

Direct peers

  • 10x Genomics: Dominant spatial biology platform company offering Visium (spatial transcriptomics) and Xenium (in situ imaging) platforms. Direct competitor to Syncell in spatial omics, serving the same pharma and academic customers with adjacent technology approaches.
  • Akoya Biosciences: Spatial proteomics company offering the PhenoCycler (CODEX) and PhenoImager platforms for multiplexed tissue imaging. Competes with Syncell for translational and immuno-oncology spatial proteomics budgets in pharma and academic core facilities.
  • Vizgen: Spatial transcriptomics company using MERFISH technology for single-cell gene expression imaging. Competes with Syncell in the broader spatial omics market, particularly for neuroscience and oncology research applications.

Broad incumbents

  • Bruker (NanoString): Acquired NanoString in 2024 and continues to offer CosMx SMI and GeoMx spatial biology platforms. Also a key mass spec instrumentation partner for Syncell through its timsTOF line, making it both a competitor and a complementary tool provider.
  • Thermo Fisher Scientific: Global life sciences instruments leader with Orbitrap mass spectrometer franchise (Orbitrap Astral). Has co-marketing partnership with Syncell but is also a potential competitive threat if it bundles proteomics upstream sample prep with its mass spec business.
  • Miltenyi Biotec: Major life science tools provider offering MACS proximity labeling (based on technology from the Ting lab) and other spatial biology workflows. Competes indirectly in spatial proteomics with broader cell biology and flow cytometry portfolios.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Syncell financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Syncell leadership team

Management profile

Number of profiles

Profiles9 records

Syncell funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Syncell M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syncell

What does Syncell do?

Syncell provides a spatial proteomics platform centered on the Microscoop Mint instrument, an integrated hardware-software-mechatronic system that uses microscopy-guided two-photon photo-biotinylation to enable unbiased, high-precision protein discovery at cellular and subcellular levels. The platform is complemented by proprietary consumable reagent kits (Synlight-Rich, Synlight-Pure, and Synpull) for photolabeling and biotinylated protein enrichment, as well as end-to-end discovery services for target and biomarker identification in pharma, biotech, and academic research settings.

Is Syncell a public or private company?

Syncell is a private company. It is classified as venture growth investor backed and is currently operating.

When was Syncell founded?

Syncell was founded in 2020. It employs 51 to 100 people.

Where is Syncell based?

Syncell is headquartered in Taipei, Taiwan, in the Asia region.

How does Syncell make money?

Three revenue lines are on record. Microscoop Mint Instruments are the primary driver. The others are reagent Kits (Synlight and Synpull) and discovery Services.

Who are Syncell's main competitors?

Emerging players on record are Ionpath, Standard BioTools (Fluidigm), Resolve Biosciences and Lunaphore. Direct peers are 10x Genomics, Akoya Biosciences and Vizgen. Broad incumbents are Bruker (NanoString), Thermo Fisher Scientific and Miltenyi Biotec.

Does Syncell have an API?

No public API is recorded for Syncell.

What industry is Syncell in?

Syncell's product category is Spatial Proteomics Instruments. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogSyncell Launches High-Precision Proteomics Discovery Service Powered by Microscoop® Mint PlatformSyncell launched Syncell Discovery Services, a global sample-to-discovery program using its Microscoop Mint platform for unbiased nanoscopic proteomics. Pilot demand outpaced capacity, with customers identifying previously unknown proteins at sites of interest. The service supports oncology, neuroscience, immunology, and cell biology, with Syncell expanding its provider network.BioSpaceSyncell Launches Ultra-High-Precision Photolabeling Kit for Nanoscopic Proteomic DiscoverySyncell Inc. launched its Synlight-Pure™ Kit, an ultra-high-precision photolabeling reagent, for their Microscoop® Mint platform to enable nanoscopic proteomic discovery in Livermore, California, and Taipei, Taiwan. The kit enhances the ability of scientists to analyze subcellular regions with 25 nanometers labeling precision, facilitating detailed cellular and molecular studies.Business Wire BlogSyncell Launches Ultra-High-Precision Photolabeling Kit for Nanoscopic Proteomic DiscoverySyncell Inc. announced the launch of its Synlight-Pure Kit, an ultra-high-precision photolabeling reagent for its Microscoop Mint platform, designed for nanoscopic proteomic discovery in biological samples. The kit provides high specificity for visualized proteome profiling and is integrated with Syncell’s existing technologies to advance drug discovery and cellular research. This development aims to improve the understanding of cellular communication and disease mechanisms.PitchBookInnovation Industrial Technology Transfer investment portfolioInnovation Industrial Technology Transfer, the venture capital arm of the Industrial Technology Research Institute, is actively investing in various industries including medical supplies and biotechnology. The firm, founded in 1979 and headquartered in Taipei, has made 53 investments and its latest was in Syncell, a company in the Medical Supplies sector. This activity highlights the firm's ongoing commitment to supporting innovation in critical sectors.Pulse 2.0Syncell: Subcellular Protein Purification Company Raises $15 Million (Series A)Syncell closed a $15 million Series A round led by Taiwania Capital, bringing total funding to $30 million. The funds will expand commercialization of its Microscoop platform for spatial proteomics. The company also signed an MOU with Thermo Fisher Scientific.citybizSyncell Raises $15M Series ASyncell, a life science company, raised $15M in Series A funding led by Taiwania Capital. The funds will expand and accelerate global commercialization of its Microscoop platform for spatial proteomics. The company expects to place Microscoop Mint instruments in the U.S., Europe, and Asia by year-end.VC News DailySyncell Announces $15 Million Series A FundingSyncell closed a $15 million Series A funding round led by Taiwania Capital, bringing its total raised to $30 million. The funds will expand and accelerate global commercialization and support for its Microscoop platform, a subcellular protein purification and spatial proteomics analysis tool.Business Wire BlogSyncell Announces $15 Million Series A Funding to Accelerate the Global Commercial Growth of Its Protein Purification and Spatial Proteomics TechnologySyncell closed a $15 million Series A funding round, bringing total raised to $30 million. The funds will support global commercialization of its Microscoop platform, with instruments planned for the U.S., Europe, and Asia by year-end. The company will showcase the technology at Cell Bio 2024 in San Diego.GlobeNewswireSyncell’s Microscoop Winner of BioTech Breakthrough Award For “Proteomics Solution of the Year”Syncell's Microscoop won Proteomics Solution of the Year in the fourth annual BioTech Breakthrough Awards. The platform enables hypothesis-free subcellular spatial proteomics by photolabeling proteins at user-defined regions of interest. Syncell plans to showcase the product at Cell Bio 2024 in San Diego.DrugdiscoverynewsA sex-specific protein panel detects early-stage cancersRyvu Therapeutics presented preclinical data on its PRMT5 inhibitor RVU305 and the ONCO Prime discovery platform at the 2025 AACR-NCI-EORTC International Conference in Boston. The company also announced that Syncell entered a strategic co-marketing agreement with Thermo Fisher Scientific to integrate Microscoop technology with Orbitrap mass spectrometers for spatial proteomics.